Recombinant Bovine G-protein coupled receptor 84 (GPR84)

What is GPR84 and what are its primary functions?

GPR84 is a G-protein coupled receptor belonging to the GPCR 1 family. It functions primarily as an enhancer of inflammatory signaling in macrophages once inflammation is established . This receptor contains seven transmembrane domains and is expressed in multiple tissues including bone marrow, brain, heart, muscle, colon, thymus, spleen, kidney, liver, placenta, intestine, lung, and peripheral blood leukocytes .

GPR84 plays a significant role in modulating inflammatory responses, particularly in macrophages. When activated, GPR84 enhances the expression and secretion of pro-inflammatory mediators such as TNFα, IL-6, and CCL2, contributing to the inflammatory cascade . Its expression is dramatically upregulated in response to inflammatory stimuli, particularly through signaling via multiple Toll-like receptors (TLRs) .

In addition to its inflammatory functions, GPR84 has been identified as essential for the taste of medium chain saturated fatty acids, suggesting a role in sensory perception .

How does bovine GPR84 compare structurally to human and murine GPR84?

While specific structural comparisons of bovine GPR84 to human and murine homologs aren't detailed in the provided search results, we can infer some information based on general GPCR conservation patterns. The human GPR84 contains 396 amino acids according to the antibody information , and the protein shows predicted reactivity across multiple species including rat, dog, cow, sheep, horse, and monkey .

The high predicted cross-reactivity suggests significant sequence conservation across mammalian species. Most GPCRs maintain highly conserved transmembrane domains while displaying greater variability in the N-terminal extracellular domain and C-terminal intracellular domain. This conservation pattern likely applies to bovine GPR84 as well, with the greatest sequence homology expected in the membrane-spanning regions responsible for ligand binding and G-protein coupling.

For experimental applications, this conservation has implications for cross-species antibody reactivity and the translational relevance of findings between bovine, murine, and human systems.

What are the known natural and synthetic ligands for GPR84?

Based on the available research data, GPR84 responds to medium-chain fatty acids as natural ligands. The synthetic agonist 6-OAU (6-octylaminouracil) has been demonstrated to effectively activate GPR84 . In experimental settings, 6-OAU at a concentration of 1 μM has been shown to significantly enhance the expression of pro-inflammatory mediators in LPS-primed macrophages .

Medium-chain saturated fatty acids appear to be particularly important natural ligands, as evidenced by GPR84's essential role in the taste perception of these compounds . The receptor's affinity for medium-chain fatty acids aligns with its increased expression during metabolic dysfunctions such as hyperglycemia and hypercholesterolemia .

It's worth noting that when designing experiments with recombinant bovine GPR84, both natural medium-chain fatty acids and synthetic agonists like 6-OAU should be considered for receptor activation studies, with the understanding that species-specific differences in ligand affinity may exist.

How is GPR84 expression regulated during inflammatory responses?

GPR84 expression is dramatically upregulated during inflammatory conditions. In experimental models of endotoxemia, LPS injection (1 mg/kg) significantly increased Gpr84 mRNA levels in mouse adipose tissue, bone marrow, brain, lung, kidney, and intestine compared to control mice, with the highest expression observed in bone marrow . This upregulation was evident at both 2 and 8 hours post-LPS administration .

At the cellular level, GPR84 is particularly upregulated in monocytes during inflammation. Cell sorting experiments revealed that monocytes, but not neutrophils or other myeloid cells, significantly increased Gpr84 mRNA expression in the bone marrow of LPS-treated mice .

In macrophage populations, GPR84 expression is significantly increased in response to pro-inflammatory "M1-like" polarization but remains at basal levels during "M2-like" anti-inflammatory polarization. Stimulation with LPS dramatically upregulates Gpr84 in various macrophage populations including bone marrow-derived macrophages (BMDMs), biogel-elicited macrophages, resident peritoneal macrophages, RAW 264.7 cells, microglia, and human monocyte-derived macrophages (hMDMs) . In contrast, stimulation with IL-4, which promotes M2 polarization, does not increase Gpr84 expression and may actually downregulate it .

Multiple pathogen-associated molecular patterns can induce GPR84 expression, with both LPS and zymosan causing significant increases that peak at approximately 8 hours post-stimulation .

What tissue distribution patterns does GPR84 exhibit in healthy versus diseased states?

During acute inflammation, such as in experimental endotoxemia models, GPR84 expression increases significantly across multiple tissues. The fold-increase in mRNA levels following LPS administration is particularly notable in:

(Note: These values are approximated from the data trends shown in Figure 1 of reference )

In atherosclerosis models, ApoE-/- mice fed a high-fat diet showed significantly increased aortic Gpr84 expression compared to those on a chow diet at both 6 and 12 weeks . Similarly, human monocyte-derived macrophages exposed to oxidized LDL (oxLDL) for 48 hours showed significantly increased GPR84 expression .

What factors influence the expression levels of GPR84 in bovine tissues?

While the search results don't specifically address bovine GPR84 expression, we can extrapolate from other mammalian models. Several key factors likely influence GPR84 expression in bovine tissues:

For researchers working with bovine GPR84, these factors should be carefully controlled or monitored to ensure reproducible experimental results.

What are the most reliable methods for detecting bovine GPR84 expression?

Based on the research data available, several methods have proven reliable for detecting GPR84 expression, though each has specific considerations for bovine applications:

• Quantitative PCR (qPCR): This appears to be the most widely used method for detecting GPR84 expression at the mRNA level. For bovine applications, researchers should design primers specific to the bovine GPR84 sequence. The TaqMan® approach has been successfully used for mouse GPR84 detection (assay ID Mm02620530_s1) , and similar commercially available assays may be available for bovine GPR84. When performing qPCR, normalization to appropriate housekeeping genes like GAPDH is essential: ΔCT(GPR84) = CT(GPR84) - CT(GAPDH) .

• Western Blotting: For protein-level detection, Western blotting using specific anti-GPR84 antibodies can be employed. The search results indicate availability of a polyclonal antibody (bs-13507R) that shows reactivity with mouse GPR84 and predicted reactivity with several other species including cow . This antibody is recommended for use at dilutions of 1:300-5000 for Western blot applications .

• ELISA: The same polyclonal antibody mentioned above is also suitable for ELISA detection at dilutions of 1:500-1000 .

It's important to note that the lack of commercially available specific antibodies against GPR84 has been a limitation in some studies . The antibody information provided indicates that the antibody (bs-13507R) is derived from a KLH-conjugated synthetic peptide from human GPR84, specifically from the region spanning amino acids 1-100 of the 396-amino acid protein . For bovine applications, validation of cross-reactivity would be recommended.

When working with recombinant bovine GPR84, expression can be confirmed using these methods, with qPCR providing information on transcript levels and Western blotting or ELISA confirming protein expression.

What are the optimal conditions for expressing and purifying recombinant bovine GPR84?

• Expression Systems: For recombinant GPCR production, several expression systems can be considered:

  • Mammalian cell lines (HEK293, CHO): These often provide the most native-like post-translational modifications and membrane insertion but at lower yields.

  • Insect cells (Sf9, Hi5): These offer a compromise between yield and proper folding.

  • Yeast (Pichia pastoris): This can provide higher yields but may have differences in glycosylation patterns.

  • E. coli: This typically offers high yield but challenges with membrane insertion and post-translational modifications.

  For bovine GPR84, a mammalian or insect cell expression system would likely provide the most functionally relevant protein.

• Construct Design: When designing expression constructs for bovine GPR84:

  • Consider adding affinity tags (His, FLAG, etc.) for purification

  • Include a cleavable signal peptide to enhance membrane insertion

  • For structural studies, thermostabilizing mutations or fusion partners (e.g., T4 lysozyme) may be beneficial

  • Codon optimization for the expression host can improve yields

• Solubilization and Purification: As a membrane protein, GPR84 requires detergent solubilization. Common detergents include DDM, LMNG, or digitonin. For purification, affinity chromatography (based on the chosen tag) followed by size exclusion chromatography is typically employed.

• Functional Validation: Purified recombinant bovine GPR84 should be validated for proper folding and function using:

  • Ligand binding assays with known GPR84 agonists like 6-OAU

  • G-protein coupling assays

  • Thermal stability assessments

It's important to note that GPR84 has been described as difficult to work with due to antibody limitations , suggesting potential challenges in expression and detection that researchers should anticipate.

What cell-based assays are most effective for studying bovine GPR84 function?

Based on the research methodologies described in the search results, several cell-based assays would be effective for studying bovine GPR84 function:

• Pro-inflammatory Mediator Production Assays: GPR84 activation enhances the expression and secretion of pro-inflammatory cytokines and chemokines. Researchers have successfully measured:

  • mRNA expression of TNFα, IL-6, and CCL2 by qPCR following GPR84 activation

  • Protein secretion of these mediators by ELISA

  This approach involves:

  • Priming cells with LPS (0.1 μg/ml for 2 hours)

  • Stimulating with a GPR84 agonist (e.g., 6-OAU at 1 μM)

  • Measuring responses at multiple time points (30, 60, 90, 120, and 240 minutes)

• Calcium Imaging: This technique has been used to study GPR84 function in taste perception . For GPR84 signaling studies:

  • Load cells with calcium-sensitive dyes

  • Stimulate with GPR84 agonists

  • Analyze the area under the curve (AUC) from the resulting calcium transients

  • Use appropriate Tyrode's buffer (containing in mM: 140 NaCl, 5 KCl, 1 CaCl2, 1 MgCl2, 10 HEPES, 10 glucose, and 10 Na pyruvate; pH 7.40)

• Macrophage Polarization Assays: Given GPR84's differential expression in M1 vs. M2 macrophages , assays examining how GPR84 activation affects polarization markers would be valuable.

• Knockout/Knockdown Validation: Using GPR84-/- cells as negative controls or GPR84 knockdown approaches can validate the specificity of observed responses .

For bovine-specific applications, these assays would need to be adapted using:

• Bovine macrophages (e.g., bovine alveolar macrophages or bone marrow-derived macrophages)

• Appropriate culture conditions for bovine cells

• Bovine-specific cytokine detection reagents for ELISAs

• Primers designed for bovine GPR84 and cytokine genes for qPCR

The statistical analysis approach used in published research includes Student's unpaired t-test or one-way analysis of variance (ANOVA) followed by Dunnett's multiple comparison post hoc test, with P < 0.05 considered statistically significant .

How does GPR84 signaling interact with other inflammatory pathways?

GPR84 functions as an enhancer of inflammatory signaling in macrophages, interacting with multiple inflammatory pathways in complex ways:

• TLR Pathway Integration: GPR84 activation appears to synergize with TLR signaling. In research models, macrophages are typically primed with LPS (activating TLR4) before GPR84 agonist treatment to observe enhanced inflammatory responses . This suggests that GPR84 may amplify ongoing inflammatory responses rather than initiating them independently.

• Pro-inflammatory Cytokine Enhancement: When activated in LPS-primed macrophages, GPR84 rapidly enhances both gene expression and protein secretion of key inflammatory mediators:

  Inflammatory Mediator	mRNA Peak Time	Protein Secretion Peak Time
  TNFα	Rapid increase	4 hours post-activation
  IL-6	Rapid increase	1 hour post-activation
  CCL2	Rapid increase	4 hours post-activation

  This temporal pattern suggests that GPR84 may differentially regulate various inflammatory mediators .

• IL-4 Regulation: In activated T cells, GPR84 has been reported to regulate early interleukin-4 (IL-4) gene expression , suggesting involvement in T cell polarization and adaptive immune responses.

• Metabolic Inflammation Cross-talk: GPR84 expression is enhanced under hyperglycemic and hypercholesterolemic conditions , indicating a potential role in metabolic inflammation. This suggests cross-talk between metabolic sensing and inflammatory signaling pathways, with GPR84 potentially serving as an integrator of these signals.

• Macrophage Polarization Influence: GPR84 is highly expressed in M1-like pro-inflammatory macrophages but not in M2-like pro-resolution macrophages . This differential expression pattern suggests that GPR84 may help maintain the pro-inflammatory phenotype of macrophages.

For researchers studying bovine inflammatory responses, understanding these pathway interactions is crucial for interpreting experimental results and designing targeted interventions.

What are the key considerations for developing GPR84 antagonists for therapeutic applications?

Development of GPR84 antagonists represents a promising therapeutic approach, particularly for inflammatory conditions. Key considerations include:

• Target Validation:

  • GPR84's role as an enhancer of inflammatory signaling in macrophages makes it a potential target for anti-inflammatory therapeutics

  • Its increased expression in hyperglycemic and hypercholesterolemic conditions suggests potential applications in metabolic disorders

  • The specific contribution of GPR84 to inflammatory pathology should be validated in disease-specific models

• Structure-Activity Relationship Development:

  • Known GPR84 agonists like 6-OAU provide starting points for antagonist development

  • Medium-chain fatty acids as natural ligands offer structural insights for competitive antagonist design

  • Species differences in the ligand-binding domain should be considered when developing antagonists for human applications based on bovine or murine studies

• Assay Systems for Screening:

  • Cell-based assays measuring inhibition of GPR84-mediated enhancement of TNFα, IL-6, and CCL2 production

  • Calcium imaging to assess inhibition of GPR84-mediated calcium signaling

  • Competitive binding assays with labeled known ligands

  • Thermal shift assays to confirm direct binding to the receptor

• Selectivity Profiling:

  • Cross-screening against other fatty acid receptors

  • Evaluation of effects on other GPCRs to minimize off-target effects

  • Assessment of species selectivity if developing therapeutics for veterinary applications

• Pharmacokinetic and Pharmacodynamic Considerations:

  • GPR84's membrane localization suggests antagonists will need appropriate lipophilicity for membrane access

  • Tissue distribution of GPR84, particularly in bone marrow, brain, and inflamed tissues , has implications for drug distribution requirements

  • The rapid enhancement of cytokine production following GPR84 activation (within hours) suggests a need for sustained target engagement

• Therapeutic Context:

  • Determining whether GPR84 antagonism would be most effective as a monotherapy or as an adjunct to existing anti-inflammatory approaches

  • Identifying specific disease states (e.g., atherosclerosis, diabetes complications, acute inflammatory conditions) where GPR84 antagonism would provide maximum benefit

A methodical approach addressing these considerations would optimize the development of GPR84 antagonists as potential therapeutics for inflammatory and metabolic disorders.

How can GPR84 knockout models be effectively utilized to study its function?

GPR84 knockout models provide powerful tools for understanding this receptor's function in various physiological and pathological contexts. Based on the search results and general principles of knockout model utilization, the following approaches are recommended:

• Generation and Validation of Knockout Models:

  • The GPR84 knockout model described in the search results was generated by replacing the GPR84 gene with a LacZ/Neo cassette by homologous recombination

  • Validation should include:

    • Genotyping to confirm knockout status

    • qPCR verification of absence of GPR84 mRNA

    • Western blot confirmation of protein absence (if suitable antibodies are available)

    • Functional assays to confirm loss of GPR84-mediated responses

• Comparative Analysis Approaches:

  • Side-by-Side Comparison: Direct comparison of wild-type and GPR84-/- cells or animals in response to stimuli

  • Rescue Experiments: Reintroduction of GPR84 into knockout cells to confirm phenotype specificity

  • Age-Matched Controls: Use of littermate controls to minimize genetic background effects

• Specific Experimental Applications:

  • Inflammatory Challenge Models: Exposing GPR84-/- and wild-type animals to LPS or other inflammatory stimuli to assess differences in cytokine production and inflammatory resolution

  • Metabolic Challenge Studies: Subjecting knockout animals to high-fat diet or hyperglycemic conditions to evaluate GPR84's role in metabolic inflammation

  • Taste Perception Analysis: Using calcium imaging and behavioral studies to assess responses to medium-chain fatty acids, leveraging GPR84's role in taste perception

• Cell-Specific Analysis:

  • Macrophage Function Studies: Isolating bone marrow-derived macrophages from GPR84-/- mice to study changes in polarization, cytokine production, and response to stimuli

  • Cross with Reporter Lines: Breeding GPR84-/- mice with lines expressing fluorescent markers in specific cell populations (e.g., GFP-PLCβ2 and GFP-GAD67 lines mentioned in the literature) to study cell-specific effects

• Data Analysis Considerations:

  • Statistical comparison between knockout and wild-type conditions using Student's unpaired t-test or ANOVA with appropriate post-hoc tests

  • Analysis of area under the curve (AUC) for temporal responses

  • Consideration of potential compensatory mechanisms that may develop in knockout models

• Experimental Design Guidelines:

  • Utilize adult (2-6 month) animals for consistency with published protocols

  • Maintain animals with water and normal chow ad libitum in a room with 12-h:12-h day/night cycle as standard conditions

  • Ensure all procedures comply with institutional animal care guidelines

By systematically applying these approaches, researchers can effectively leverage GPR84 knockout models to elucidate this receptor's function in various physiological and pathological contexts.

What is the role of GPR84 in metabolic disorders and potential therapeutic implications?

Research indicates that GPR84 plays a significant role in metabolic disorders, particularly at the intersection of metabolism and inflammation:

• Diabetic Conditions:

  • GPR84 mRNA expression is significantly upregulated in bone marrow, brain, and kidney of diabetic NOD mice compared to non-diabetic controls

  • In vitro, BMDMs exposed to high glucose conditions (25 mM D-glucose) show significantly increased GPR84 expression compared to those in low glucose (5.5 mM) conditions

  • The response is specific to metabolically active D-glucose, as L-glucose does not induce similar upregulation

• Dyslipidemia and Atherosclerosis:

  • ApoE-/- mice (a model of atherosclerosis) fed a high-fat diet show significantly increased aortic GPR84 expression compared to those on a chow diet at both 6 and 12 weeks

  • Human monocyte-derived macrophages exposed to oxidized LDL (oxLDL) for 48 hours show significantly increased GPR84 expression

  • This suggests GPR84 may contribute to foam cell formation and atherosclerotic plaque development

• Mechanism of Involvement:

  • GPR84 likely serves as a bridge between metabolic stress and inflammatory activation

  • Its upregulation during metabolic stress may enhance macrophage inflammatory responses to subsequent stimuli

  • Medium-chain fatty acids, which are natural ligands for GPR84, may be elevated during certain metabolic conditions, providing increased activation signals

• Therapeutic Implications:

  • Anti-inflammatory Approach: GPR84 antagonists could potentially reduce metabolic inflammation without broadly suppressing immune function

  • Macrophage Phenotype Modulation: Targeting GPR84 might shift macrophage polarization from pro-inflammatory M1 to anti-inflammatory M2 in metabolic tissues

  • Tissue-Specific Targeting: The differential upregulation of GPR84 in specific tissues during diabetes (bone marrow, brain, kidney) suggests potential for targeted therapeutic approaches

• Research Gaps and Future Directions:

  • The precise signaling mechanisms linking GPR84 activation to metabolic inflammation require further elucidation

  • The relative contribution of GPR84 to metabolic disease progression compared to other inflammatory pathways needs quantification

  • The potential for GPR84-targeted therapies to improve insulin sensitivity, reduce atherosclerosis, or ameliorate diabetic complications remains to be fully explored

These findings suggest that GPR84 may be a valuable therapeutic target for the treatment of metabolic disorders, particularly those with a significant inflammatory component.

How can species differences in GPR84 function impact translational research?

Species differences in GPR84 function can significantly impact translational research in several important ways:

Recognizing and accounting for these species differences is crucial for researchers working with bovine GPR84 who aim to generate findings with translational relevance to human health and disease.

What are the most promising techniques for studying GPR84-ligand interactions?

Understanding GPR84-ligand interactions is critical for both basic research and drug development. Based on the available research and general approaches in GPCR pharmacology, the following techniques are most promising:

• Computational Approaches:

  • Homology Modeling: Creating structural models of bovine GPR84 based on crystal structures of related GPCRs

  • Molecular Docking: Predicting binding modes of known ligands like medium-chain fatty acids and 6-OAU

  • Molecular Dynamics Simulations: Exploring the dynamic interactions between GPR84 and its ligands over time

  • Pharmacophore Modeling: Identifying key structural features required for GPR84 activation or inhibition

• Binding Assays:

  • Radioligand Binding: Using radiolabeled ligands to measure direct binding to GPR84

  • Fluorescence-Based Binding: Employing fluorescent ligands and techniques like fluorescence polarization or FRET

  • Surface Plasmon Resonance: Measuring real-time binding kinetics of ligands to immobilized recombinant GPR84

  • Thermal Shift Assays: Assessing ligand-induced stabilization of the receptor

• Functional Readouts:

  • Calcium Imaging: Measuring intracellular calcium responses following GPR84 activation, as described in the taste receptor studies

  • cAMP Assays: Quantifying changes in cAMP levels in response to GPR84 ligands

  • β-Arrestin Recruitment: Monitoring β-arrestin recruitment as a measure of receptor activation

  • MAPK Phosphorylation: Assessing activation of downstream MAPK pathways following GPR84 stimulation

• Structural Biology Techniques:

  • Cryo-EM: Determining the structure of GPR84 in different conformational states

  • X-ray Crystallography: If crystals can be obtained, providing high-resolution structural information

  • HDX-MS (Hydrogen-Deuterium Exchange Mass Spectrometry): Identifying regions of conformational change upon ligand binding

  • Site-Directed Mutagenesis: Systematically mutating potential ligand-binding residues to map the binding pocket

• Advanced Cellular Techniques:

  • BRET (Bioluminescence Resonance Energy Transfer): Measuring ligand-induced conformational changes and protein-protein interactions

  • FRET (Fluorescence Resonance Energy Transfer): Similar to BRET but using fluorescent proteins

  • Label-Free Technologies: Measuring whole-cell responses to GPR84 activation without artificial labels

  • Single-Cell Analysis: Examining heterogeneity in GPR84 responses across cell populations

• Innovative Approaches:

  • Nanobodies: Using camelid antibody fragments to stabilize specific receptor conformations

  • Biosensors: Developing genetically encoded sensors that report on GPR84 activation status

  • Native Mass Spectrometry: Analyzing GPR84-ligand complexes in near-native conditions

  • Covalent Labeling: Using specially designed ligands that form covalent bonds with the receptor to trap specific states

For researchers studying bovine GPR84, a multifaceted approach combining computational methods with appropriate binding and functional assays would provide the most comprehensive understanding of ligand interactions and guide the development of species-specific modulators.